| Antioxidants and lipid peroxidation status in diabetic patients with and without complications R Srivatsan, S Das, R Gadde, KK MANOJ, S Taduri, N Rao, A Baharani, ... ARCHIVES OF IRANIAN MEDICINE 12 (2), 121-127, 2009 | 126 | 2009 |
| Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5 R Mitra, TT Le, P Gorjala, OB Goodman Jr BMC cancer 17 (1), 1-12, 2017 | 68 | 2017 |
| Genetic ancestry analysis reveals misclassification of commonly used cancer cell lines. KR Hooker SE, Woods-Burnham L, Bathina M, Lloyd SM, Gorjala P, Mitra R, Nonn ... Cancer Epidemiol Biomarkers Prev, 2019 | 38 | 2019 |
| p53‐dependent up‐regulation of CDKN1A and down‐regulation of CCNE2 in response to beryllium P Gorjala, JG Cairncross, RK Gary Cell Proliferation 49 (6), 698-709, 2016 | 18 | 2016 |
| Capillary Isoelectric Focusing Immunoassay for Fat Cell Differentiation Proteomics MG Johlfs, P Gorjala, Y Urasaki, TT Le, RR Fiscus PloS one 10 (7), e0132105, 2015 | 17 | 2015 |
| Pancreatic-β-cell survival and proliferation are promoted by protein kinase G type Iα and downstream regulation of AKT/FOXO1 JC Wong, V Vo, P Gorjala, RR Fiscus Diabetes and Vascular Disease Research 14 (5), 434-449, 2017 | 15 | 2017 |
| Beryllium is an inhibitor of cellular GSK-3β that is 1,000-fold more potent than lithium SR Mudireddy, ARM Abdul, P Gorjala, RK Gary BioMetals 27 (6), 1203-1216, 2014 | 14 | 2014 |
| Beryllium sulfate induces p21 CDKN1A expression and a senescence-like cell cycle arrest in susceptible cancer cell types P Gorjala, RK Gary BioMetals 23 (6), 1061-1073, 2010 | 12 | 2010 |
| Role of CYP3A5 in modulating androgen receptor signaling and its relevance to African American men with prostate cancer P Gorjala, RA Kittles, OB Goodman, R Mitra Cancers 12 (4), 989, 2020 | 7 | 2020 |
| Characterization of Beryllium as a Novel Agent to Study Cell Cycle Arrest and Cellular Senescence P Gorjala | | 2012 |
Thuc T. LeRoseman University of Health SciencesVerified email at roseman.edu
